Nektar Therapeutics

8-K Shareholder vote results Jun 5, 2026 8-K Entered a material agreement; Director or officer change May 8, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Other events Apr 23, 2026 8-K Regulation FD disclosure Apr 20, 2026 8-K Regulation FD disclosure; Other events Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Entered a material agreement; Other events Feb 13, 2026 8-K Regulation FD disclosure Feb 10, 2026 8-K Regulation FD disclosure; Other events Feb 10, 2026 8-K Regulation FD disclosure Jan 27, 2026 8-K Regulation FD disclosure; Other events Dec 16, 2025 8-K Director or officer change Nov 21, 2025 8-K Regulation FD disclosure; Other events Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure; Other events Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Entered a material agreement; Other events Jul 1, 2025 8-K Other events Jun 27, 2025 8-K Regulation FD disclosure; Other events Jun 24, 2025 8-K Amended charter or bylaws Jun 6, 2025 8-K Other events Jun 4, 2025 8-K Shareholder vote results May 28, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Delisting notice or listing-rule failure Apr 4, 2025 8-K Entered a material agreement Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 14, 2025 8-K Results of operations (earnings release) Mar 12, 2025 8-K Other events Feb 24, 2025 8-K Other events Feb 4, 2025 8-K Completed an acquisition or disposition Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Entered a material agreement; Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024